Other relevant immunological biomarkers were found significantly different between the two patients’ groups: ALS showed higher amounts of CD3 and CD4, IL3, IL8, and lower levels of CD19 lymphocytes, soluble IL2R, soluble IL6R, TNF, TNFRs, and IL12 (Table 2). This evidence concerns the gene TNF and amyotrophic lateral sclerosis.